Hanmi Pharmaceuticals Co Ltd - Company Profile
Powered by 
All the data and insights you need on Hanmi Pharmaceuticals Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Hanmi Pharmaceuticals Co Ltd Strategy Report
- Understand Hanmi Pharmaceuticals Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Hanmi Pharmaceuticals Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Hanmi Pharmaceuticals Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 18 Aug 2017 | Lorem |
| Spectrum Pharmaceuticals scouting for US-based CMOs, pursues multiple licensing agreements - CEO | 13 May 2015 | Katie McQue |
| Spectrum aims to move its G-CSF candidate into Phase III chemo-induced neutropenia trial by YE14 - exec | 23 Jan 2014 | Juliana Wexler |
| Hanmi Pharmaceutical expects FDA approval for generic Nexium in August, market launch by YE | 26 Jun 2013 | Kimberly Ha |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer